Behnoush Zare, PhD

Present title & Affiliation

Primary Appointment:

  in Middle East Gene Therapy Co., National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.

Senior Expert on Tissue, Cell and Gene Therapy group, Biologics Office, IFDA.

Education & Training

Degree-Granting Education

2009    Ph.D.in Pharmacology, Iran University of Medical Sciences 

2001    Doctorate in Pharmacy (Pharm.D.), Shahid Beheshti University of Medical Sciences 

Postgraduate Training

18th PIC/S Expert Circle on Human Blood, Tissues and Cells, Ravimiamet, State Agency of Medicine, Tallinn, Estonia, 2011. 

20th Circle on Medical Education for Academic Members, Tehran University of Medical Sciences, Tehran, Iran, 2012. 

20th PIC/S Expert Circle Meeting on Human Blood, Tissues and Cells, TFDA, Taiwan, Taipei, 2013. 

WHO Global Learning Course on Vaccine Product Evaluation, Tunis, Tunisia, 2014. 

Therapeutic Antibodies: Discovery, Engineering and Development International MasterClass, Amsterdam, The Netherlands, 17th-18th March 2015. 

21th PIC/S Expert Circle Meeting on Human Blood, Tissues and Cells, AIFA, Rome, Italy, 2015. 

6th Training Seminar for International Regulatory Authorities on Adverse Drug reaction and Events, Tokyo, Japan, 2015. 

Human Blood, Tissues and Cells, Ravimiamet, State Agency of Medicine, Tallinn, Estonia. 

Experience & Service

2013-2016       Expert on Recombinant Biological Products, Biologics Office, IFDA.

2010- 2013    Assistant Professor, Department of Pharmacology, School of Medicine, Iran University of Medical Sciences 

2001-2004       Expert on medicinal products, Registration Office, Ministry of Health and Medical Education 

Expert Training

Regulatory Affairs of Biological Products 

Clinical trial Documentation

Cell therapy FDA regulations

Gene therapy FDA regulations

Honors & Awards

The Best Article Presented in the 5th Congress on Immunology, Asthma and Allergy at Tarbiat Modarres University, Tehran, 1999.

The Selected Teaching Method in 5th Shahid Motahari Congress on Medical Education, Tehran University of Medical Sciences, Tehran, 2012. (Has been participated on behalf of the Tehran University of Medical Sciences to the 5th National Shahid Motahari Congress on Medical Education in the Ministry of Health and Medical Education). 

The Best Teaching Method in the 5th National Shahid Motahari Congress on Medical Education in the Ministry of Health and Medical Education, 2012.

Publications & Books

Behnoush Zare et al., Regulatory Standards of Biological Products in Iran, Book, 2018, 1st edition, 978-600-408-531-1. 

A.M. Sharifi, B. Zare, M. Keshavarz, M. Rahmani, B. Zaeefy, B. Larijani. Urinary N-Acetyl-β-D-Glocosaminidase (NAG) Activity in the Early Detection of Diabetic Nephropathy, Int J Diabetes Dev Ctries, 2015; 35(3): 369-374. 

Zare. B, Cheraghali, A. Regulation on Cell Therapy Products in Iran, Basic & Clinical Pharmacology & Toxicology, 2014; 115: 336. 

Behnoush Zare, Mojdeh Akhavan, Ahmad Reza Dehpour, Insertion of Pioglitazone into the Carbon Nanotube. World Academy of Science, Engineering and Technology, 2012; 66: 311-315. 4 

Zare, A. M.Sobhani, S. Dastmalchi, M. Mahmoudian. Homology modeling, molecular dynamics simulation and ligand docking of human prostanoid E1 receptor. Sci.Pharm. 2011; 79: 793-816. 

A.M. Sharifi, B. Zare, M. Keshavarz, M. Ghaderpanahi. Effect of short term treatment of L-carnitine on tissue ACE activity in streptozotocin-induced diabetic rats. Pathophysiology, 2009; 16(1):53-56. 

Behnoush Zare, Armin Madadkar Sbhani, Siavoush Dastmalchi, Massoud Mahmoudian. Modeling of the hEP1 receptor based on the crystallographic structure of β2-adrenergic receptor and its assessment with docking studies and molecular dynamics simulation. DARU Journal of Pharmaceutical Sciences. 2009; 17(4): 299-307.